Your browser doesn't support javascript.
loading
From theory to practice: Implementing next-generation sequencing and public health genomics in healthcare systems.
Horgan, Denis; Pesapane, Filippo; Van der Buckle, Marc; de Maria, Ruggero; Dube, France; Singh, Jaya; Lugowska, Iwona; Bayle, Arnaud; Hofman, Paul; Malapelle, Umberto; Hills, Tanya; Capoluongo, Ettore D; Subbiah, Vivek.
Affiliation
  • Horgan D; European Alliance for Personalised Medicine, Brussels 1040, Belgium; Department of Molecular and Cellular Engineering, Jacob Institute of Biotechnology and Bioengineering, Faculty of Engineering and Technology, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, In
  • Pesapane F; Breast Imaging Division, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Van der Buckle M; Belgian Cancer Centre, Sciensano, Brussels 1050, Belgium.
  • de Maria R; Institute of General Pathology, Catholic University of the Sacred Heart, Rome 20123, Italy.
  • Dube F; Astra Zeneca, Concord Pike, Wilmington, DE 19803, USA.
  • Singh J; European Alliance for Personalised Medicine, Brussels 1040, Belgium.
  • Lugowska I; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Roentgena 5, Warsaw 02-781, Poland.
  • Bayle A; Drug Development Department (DITEP), Gustave Roussy - Cancer Campus, Université Paris Sacla, Villejuif, France.
  • Hofman P; European Liquid Biopsy Society, Hamburg, Germany.
  • Malapelle U; Department of Public Health, University Federico II of Naples, Naples 80138, Italy.
  • Hills T; Boehringer Ingelheim International GmbH, Binger Str. 173, Ingelheim am Rhein 55218, Germany.
  • Capoluongo ED; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples 80138, Italy; Department of Clinical Pathology, Azienda Ospedaliera San Giovanni Addolorata, Via Amba Aradam 8, Rome 00184, Italy.
  • Subbiah V; Sarah Cannon Research Institute, Nashville, TN 37203, USA. Electronic address: Vivek.Subbiah@scri.com.
Crit Rev Oncol Hematol ; 201: 104433, 2024 Jun 30.
Article in En | MEDLINE | ID: mdl-38955310
ABSTRACT
If Europe's health systems make a conscious decision to increase their utilization of technology and techniques that can enhance prevention and expedite early-stage diagnosis, they can effectively address the growing challenges of disease. By embracing these advancements, these health systems can significantly improve their response to emerging health issues.However, at present the effective integration and exploitation of these opportunities remains hesitant and suboptimal, and health and health services underperform accordingly, with patients suffering from the continuing variations in diagnosis and access to innovation. This paper presents a comprehensive study that examines the current state of various influential disciplines and factors in European countries. It specifically focuses on the adoption of Next Generation Screening technologies and the development stage of Public Health Genomics. The assessment of these areas is presented in the context of a rapidly changing policy environment, which provides an opportunity for a fundamental reconsideration of how and where new tools can be integrated into healthcare systems and routine practices. Top of Form.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Crit Rev Oncol Hematol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Crit Rev Oncol Hematol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2024 Document type: Article